ArticleHead and neck pathology2026
Oral Melanoma: A South American Collaborative Series of 21 Cases.
Article in Head and neck pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral melanoma is a rare and aggressive malignant neoplasm that typically exhibits variable degrees of pigmentation. Amelanotic variants further complicate clinical diagnosis by mimicking non-neoplastic lesions. The present study aimed to describe the clinicopathological characteristics, management, and outcomes of oral melanoma in South America.
methodsThis collaborative retrospective study included cases diagnosed between 2003 and 2025 from five oral pathology and oral medicine centers in Argentina, Venezuela, Colombia, and Brazil. Clinicopathological, treatment, and follow-up data were analyzed descriptively.
resultsTwenty-one cases of primary oral melanoma were analyzed. The mean age was 63.0 years, with a slight female predominance (52.4%). Most lesions were asymptomatic at diagnosis (78.3%) and involved the palate/maxillary gingiva (66.7%). Clinically, tumors (37.9%) and macules (27.6%) were the most frequent presentations. Histologically, melanotic melanoma predominated (76.2%). Melan-A, HMB-45, SOX10, and S-100 protein were the most frequently used immunohistochemical markers. Surgical resection was performed in 85.7% of cases. During follow-up, 52.6% of patients died.
conclusionData corroborate the clinicopathological profile of oral melanoma and expand current knowledge by documenting novel South American cases, underscoring its marked clinical heterogeneity, poor prognosis, and the critical importance of early recognition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.